Pharmala Biotech Holdings Buy Hold or Sell Recommendation
| PMBHFDelisted Stock | 0.25 0.00 0.00% |
Assuming the 90 days horizon and your complete indifference towards market risk, our recommendation regarding Pharmala Biotech Holdings is 'Not Rated'. Macroaxis provides Pharmala Biotech buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding PMBHF positions.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. Note, we conduct extensive research on individual companies such as Pharmala and provide practical buy, sell, or hold advice based on investors' constraints. Pharmala Biotech Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Pharmala |
Execute Pharmala Biotech Buy or Sell Advice
The Pharmala recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Pharmala Biotech Holdings. Macroaxis does not own or have any residual interests in Pharmala Biotech Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Pharmala Biotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Pharmala Biotech Trading Alerts and Improvement Suggestions
| Pharmala Biotech is not yet fully synchronised with the market data | |
| Pharmala Biotech has some characteristics of a very speculative penny stock |
Pharmala Biotech Returns Distribution Density
The distribution of Pharmala Biotech's historical returns is an attempt to chart the uncertainty of Pharmala Biotech's future price movements. The chart of the probability distribution of Pharmala Biotech daily returns describes the distribution of returns around its average expected value. We use Pharmala Biotech Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Pharmala Biotech returns is essential to provide solid investment advice for Pharmala Biotech.
| Mean Return | 0.29 | Value At Risk | -17.39 | Potential Upside | 4.17 | Standard Deviation | 14.89 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Pharmala Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Pharmala Biotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Pharmala . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Use Investing Ideas to Build Portfolios
In addition to having Pharmala Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SRI Sustainable Growth Thematic Idea Now
SRI Sustainable Growth
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Pharmala Pink Sheet
If you are still planning to invest in Pharmala Biotech Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pharmala Biotech's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |